COUMARINES USEFUL AS BIOMARKERS

Details for Australian Patent Application No. 2003210418 (hide)

Owner NOVARTIS AG

Inventors AUBERSON, Yves

Pub. Number AU-A-2003210418

PCT Number PCT/EP03/02251

PCT Pub. Number WO2003/074519

Priority 0205281.9 06.03.02 GB

Filing date 5 March 2003

Wipo publication date 16 September 2003

International Classifications

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 0205281.9 06.03.02 GB

23 October 2003 Application Open to Public Inspection

  Published as AU-A-2003210418

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210419-USE OF AN L-ASCORBIC ACID SALT TO PREPARE A PHARMACEUTICAL COMPOSITION FOR OPHTALMIC TOPICAL USE CAPABLE OF IMPROVING THE LEVEL OF LASCORBIC ACID IN THE EYE

2003210417-Transdermal system comprising fentanyl